Henry H. Balfour
#125,328
Most Influential Person Now
Henry H. Balfour's AcademicInfluence.com Rankings
Henry H. Balfourphilosophy Degrees
Philosophy
#5851
World Rank
#8771
Historical Rank
Logic
#3061
World Rank
#4164
Historical Rank
Henry H. Balfourbiology Degrees
Biology
#7886
World Rank
#10875
Historical Rank
Immunology
#428
World Rank
#445
Historical Rank
Download Badge
Philosophy Biology
Henry H. Balfour's Degrees
- Doctorate Medicine Harvard University
- PhD Immunology Stanford University
Why Is Henry H. Balfour Influential?
(Suggest an Edit or Addition)Henry H. Balfour's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. (1997) (2544)
- Virus‐associated hemophagocytic syndrome A benign histiocytic proliferation distinct from malignant histiocytosis (1979) (1015)
- Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. (1990) (1006)
- Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue (1996) (642)
- Survival of influenza viruses on environmental surfaces. (1982) (535)
- A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. (1989) (490)
- Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. (1982) (429)
- Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. (1989) (404)
- Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. (1983) (380)
- Cytomegalovirus Disease in Renal Allograft Recipients: A Prospective Study of the Clinical Features, Risk Factors and Impact on Renal Transplantation (1980) (373)
- Acyclovir halts progression of herpes zoster in immunocompromised patients. (1983) (357)
- Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections (2011) (349)
- Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. (1990) (324)
- Respiratory syncytial virus infection in immunocompromised adults. (1988) (297)
- Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. (1986) (274)
- Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. (2013) (260)
- Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. (1990) (254)
- Therapy of herpes zoster with oral acyclovir. (1988) (254)
- Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. (1993) (251)
- Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. (1982) (237)
- Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. (1987) (232)
- Parainfluenza virus respiratory infection after bone marrow transplantation. (1992) (218)
- Drug therapy : Antiviral drugs (1999) (205)
- Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. (2013) (195)
- A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. (2005) (181)
- Primary Epstein-Barr virus infection. (2018) (179)
- Human pharmacokinetics of the antiviral drug DHPG (1986) (179)
- Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. (1998) (177)
- Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results. (1989) (174)
- Acyclovir treatment of varicella in otherwise healthy children. (1990) (173)
- Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. (1991) (169)
- The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. (2013) (168)
- Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. (1998) (166)
- Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. (1997) (150)
- Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. (1987) (149)
- Human immunodeficiency virus infection in patients with solid-organ transplants: report of five cases and review. (1991) (145)
- Clinical and Laboratory Evaluation of Cytomegalovirus‐Induced Mononucleosis in Previously Healthy Individuals: REPORT OF 82 CASES (1986) (144)
- Cutting Edge: NKG2ChiCD57+ NK Cells Respond Specifically to Acute Infection with Cytomegalovirus and Not Epstein–Barr Virus (2014) (143)
- Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. (1992) (142)
- Varicella in children with renal transplants. (1981) (136)
- Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening. (1991) (134)
- EBV-positive Mucocutaneous Ulcer in Organ Transplant Recipients: A Localized Indolent Posttransplant Lymphoproliferative Disorder (2014) (132)
- Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. (1994) (132)
- The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. (1994) (131)
- Rapid and sensitive viral culture method for human immunodeficiency virus type 1 (1988) (129)
- Multicenter Comparison of Different Real-Time PCR Assays for Quantitative Detection of Epstein-Barr Virus (2007) (126)
- Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings (2012) (125)
- CYTOMEGALOVIRUS AS A RISK FACTOR IN RENAL TRANSPLANTATION (1980) (121)
- Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. (1977) (116)
- Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells (1994) (114)
- Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals (1990) (112)
- Cytomegalovirus: Clinical Virological Correlations in Renal Transplant Recipients (1974) (110)
- Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS. (1994) (108)
- Infectious Diseases in Hospitalized Renal Transplant Recipients: A Prospective Study of a Complex and Evolving Problem (1982) (106)
- Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes (1992) (104)
- Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. (1991) (100)
- Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases. (1977) (96)
- Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants. (1981) (90)
- Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis. (1998) (89)
- Transmission of hepatitis B virus in clinical laboratory areas. (1979) (87)
- The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events (2015) (86)
- A virologic pilot study of valacyclovir in infectious mononucleosis. (2007) (82)
- Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution. (1982) (81)
- Practical diagnostic testing for human immunodeficiency virus (1988) (80)
- Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. (1993) (79)
- Concurrent zidovudine levels in semen and serum determined by radioimmunoassay in patients with AIDS or AIDS-related complex. (1988) (79)
- A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team. (1998) (78)
- Primary Epstein-Barr virus infection does not erode preexisting CD8+ T cell memory in humans (2012) (76)
- In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir. (1987) (76)
- Epstein-Barr virus antibody responses and clinical illness in renal transplant recipients. (1979) (76)
- Cytomegalovirus is not an occupational risk for nurses in renal transplant and neonatal units. Results of a prospective surveillance study. (1986) (75)
- Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. (1988) (75)
- A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. (1994) (74)
- Resistance of herpes simplex to acyclovir. (1983) (73)
- Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. (1992) (73)
- Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. (1989) (73)
- Management of cytomegalovirus disease with antiviral drugs. (1990) (73)
- Zidovudine-associated myopathy. (1989) (71)
- Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis. (1993) (67)
- A trial of vidarabine for cytomegalovirus infection in renal transplant patients. (1980) (67)
- Infectious mononucleosis (2015) (66)
- A longitudinal analysis of lymphocyte proliferative responses to mitogens and antigens during human pregnancy. (1981) (65)
- Encephalitis associated with erythema infectiosum. (1970) (65)
- Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine. (1989) (62)
- Intravenous acyclovir therapy for varicella in immunocompromised children. (1984) (62)
- California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis. (1973) (60)
- Fever in renal transplant recipients: causes, prognostic significance and changing patterns at the University of Minnesota Hospital. (1981) (59)
- Age-specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race/ethnicity and family environment. (2014) (59)
- Cytomegalovirus-specific humoral and cellular immune responses in human pregnancy. (1981) (56)
- An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma. (2007) (53)
- Varicella-Zoster virus does not become more resistant to acyclovir during therapy. (1986) (52)
- Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1 (1988) (52)
- Cytomegalovirus: the troll of transplantation. (1979) (51)
- Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. (1992) (50)
- Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management. (1988) (49)
- Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients. (1983) (49)
- Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes. (1977) (48)
- Periodontal status of individuals in early stages of human immunodeficiency virus infection. (1991) (48)
- Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein (1993) (47)
- Primary Epstein-Barr virus infection with and without infectious mononucleosis (2019) (47)
- Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review. (1994) (46)
- Rubella, measles and mumps antibodies following vaccination of children. A potential rubella problem. (1978) (46)
- Infectious Mononucleosis. (2015) (45)
- Antiviral drugs. (1999) (43)
- Progress, prospects, and problems in Epstein-Barr virus vaccine development. (2014) (42)
- Clinical and laboratory evaluation of infants and children with Epstein-Barr virus-induced infectious mononucleosis: report of 32 patients (aged 10-48 months). (1981) (42)
- Acyclovir therapy in neonates. (1991) (41)
- Juvenile xanthogranuloma associated with cytomegalovirus infection. (1971) (40)
- Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients (1991) (39)
- Viral infections in renal transplant donors and their recipients: a prospective study. (1977) (39)
- The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. (2010) (38)
- Cytomegalovirus vaccine trial in 400 renal transplant candidates (1985) (37)
- Primary EBV Infection Induces an Expression Profile Distinct from Other Viruses but Similar to Hemophagocytic Syndromes (2014) (37)
- Erythema Infectiosum (Fifth Disease) (1969) (36)
- Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. (1988) (36)
- Prevention or modification of varicella using zoster immune plasma. (1977) (36)
- Acyclovir therapy for herpes zoster: advantages and adverse effects. (1986) (34)
- Continuous infusion of high-dose acyclovir for serious herpesvirus infections (1989) (34)
- Antiviral Therapy of Varicella-Zoster Virus Infections (1988) (33)
- Cytomegalovirus replicates efficiently in human kidney mesangial cells. (1988) (33)
- Ganciclovir treatment of cytomegalovirus disease in immunocompromised children (1989) (33)
- Varicella arthritis documented by isolation of virus from joint fluid. (1978) (33)
- How should zoster trials be conducted? (1995) (33)
- Predictive value of HIV-1 viral load on risk for opportunistic infection. (2002) (32)
- Cytomegalovirus vaccine in renal transplant candidates: progress report of a randomized, placebo-controlled, double-blind trial. (1984) (32)
- Hemophiliacs with HIV antibody are actively infected. (1988) (32)
- Serum p24 antigen level as an intermediate end point in clinical trials of zidovudine in people infected with human immunodeficiency virus type 1. Aids Clinical Trials Group Virology Laboratories. (1994) (31)
- Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV (2016) (31)
- Risk factors in the development of cytomegalovirus-related pneumonia in renal transplant recipients. (1983) (31)
- Acyclovir for Treatment of Postherpetic Neuralgia: Efficacy and Pharmacokinetics (2001) (30)
- Cytomegalovirus vaccine. Specific humoral and cellular immune responses in human volunteers. (1980) (30)
- Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS (1996) (30)
- Foscarnet for suppression of human immunodeficiency virus replication (1994) (30)
- Evaluation of Ganciclovir for Cytomegalovirus Disease (1989) (30)
- Prospective studies of infectious mononucleosis in university students (2016) (29)
- Long-term follow-up of health care workers with work-site exposure to human immunodeficiency virus. (1990) (29)
- Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load. (2013) (29)
- Cytomegalovirus infection of the liver in transplant recipients. (1987) (29)
- The Impact of Donor Viral Replication at Transplant on Recipient Infections Posttransplant: A Prospective Study (2015) (27)
- Epstein–Barr virus dynamics in asymptomatic immunocompetent adults: an intensive 6-month study (2016) (27)
- Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis (1993) (27)
- Complications of Fetal Blood Sampling (1970) (27)
- Jaundice after Renal Allotransplantation (1978) (26)
- Chronic granulomatous disease of childhood in a 23-year-old man. (1971) (26)
- Semen and Serum Pharmacokinetics of Zidovudine and Zidovudine‐Glucuronide in Men with HIV‐1 Infection (2000) (25)
- Cytomegalovirus infection in infancy: virological and immunological studies. (1982) (24)
- Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes (1992) (24)
- Pharmacokinetics and safety of high‐dose oral acyclovir for suppression of cytomegalovirus disease after renal transplantation (1988) (23)
- Valganciclovir Administration to Kidney Donors to Reduce the Burden of Cytomegalovirus and Epstein-Barr Virus Transmission During Transplantation (2015) (23)
- Evaluation of zoster immune plasma. Treatment of cutaneous disseminated zoster in immunocompromised patients. (1978) (22)
- Congenital cytomegalovirus infection as a result of nonprimary cytomegalovirus disease in a mother with acquired immunodeficiency syndrome. (1995) (22)
- Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients. (2014) (22)
- Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction (2015) (21)
- Cell-mediated immunity to murine cytomegalovirus. (1978) (21)
- Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation. (2015) (20)
- Current management of varicella zoster virus infections (1993) (20)
- Isolates of California encephalitis (La Crosse) virus from field-collected eggs and larvae of Aedes triseriatus: identification of the overwintering site of California encephalitis. (1975) (20)
- Microglial cell upregulation of HIV-1 expression in the chronically infected promonocytic cell line U1: the role of tumor necrosis factor-α (1992) (20)
- Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. (1991) (20)
- Cytomegalovirus vaccine in renal allograft recipients. (1981) (20)
- Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else? (2007) (19)
- Acyclovir treatment for varicella does not lower gpI and IE-62 (p170) antibody responses to varicella-zoster virus in normal children (1990) (19)
- A Randomized Crossover Study to Determine Bioequivalence of Generic and Brand Name Nevirapine, Zidovudine, and Lamivudine in HIV-Negative Women in India (2006) (19)
- Recovery of HIV at autopsy. (1989) (19)
- Acyclovir and other chemotherapy for herpes group viral infections. (1984) (19)
- Opiates, human peripheral blood mononuclear cells, and HIV. (1991) (19)
- Acyclovir in shingles. (1983) (18)
- Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection. (2013) (18)
- Rubella reimmunization now. (1979) (18)
- A study of erythema infectiosum: recovery of rubella virus and echovirus-12. (1972) (17)
- Penicillin-related Exanthems in Infectious Mononucleosis Identical to Those Associated with Ampicillin (1972) (17)
- Specific Detection of Human BK Polyomavirus in Urine Samples of Immunocompromised Patients (2003) (17)
- Prevention of cytomegalovirus disease in renal allograft recipients. (1991) (16)
- SPECIFIC CELL-MEDIATED IMMUNE DEFECT IN CONGENITAL CYTOMEGALOVIRUS INFECTION (1977) (16)
- Evaluation of Wistar RA27/3 rubella virus vaccine in children. (1976) (16)
- Viral infections in kidney donors and recipients: a prospective study. (1977) (16)
- Laboratory studies of acute varicella and varicella immune status. (1988) (16)
- Evaluation of centrifugation cultures of bronchoalveolar lavage fluid for the diagnosis of cytomegalovirus pneumonitis. (1988) (16)
- Cytomegalovirus disease: can it be prevented? (1983) (15)
- Infection in immunosuppressed transplant recipients. (1975) (15)
- The AIDS Clinical Trials Group (1990) (15)
- Cytomegalovirus vaccine: persistence of humoral immunity following immunization of renal transplant candidates. (1984) (15)
- Antiviral drugs in pediatrics. (1989) (14)
- Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-α2B and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection (1999) (14)
- California Arbovirus (La Crosse) Infections II. Precipitin Antibody Tests for the Diagnosis of California Encephalitis (1973) (14)
- Recombinant human erythropoietin for treatment of anemia in persons with AIDS not receiving zidovudine. (1997) (13)
- Pharmacokinetics of hyperimmune anti-human immunodeficiency virus immunoglobulin in persons with AIDS (1997) (13)
- The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post‐transplant: A prospective study (2017) (13)
- Acyclovir: an effective antiviral. (1981) (13)
- Zoster immune plasma prophylaxis of varicella: a follow-up report. (1979) (13)
- Optimal method for recovery of cytomegalovirus from urine of renal transplant patients. (1977) (13)
- No reason not to treat (1995) (13)
- RA27/3 rubella vaccine. A four-year follow-up. (1980) (13)
- The auriculotemporal syndrome beginning in infancy. (1970) (13)
- Coprevalence of Epstein-Barr Virus, Cytomegalovirus, and Herpes Simplex Virus Type-1 Antibodies Among United States Children and Factors Associated With Their Acquisition. (2015) (12)
- Epstein-Barr Virus DNA in Parental Oral Secretions: A Potential Source of Infection for Their Young Children (2019) (12)
- Prevention of Morbidity and Mortality of Wild Murine Cytomegalovirus by Vaccination with Attenuated Cytomegalovirus 1 (1977) (12)
- Strategies for control of zidovudine concentrations in serum (1995) (12)
- Brain scan in a patient with herpes simplex encephalitis. (1967) (12)
- Measles (rubeola) susceptibility among elementary schoolchildren. (1975) (12)
- Options for prevention of cytomegalovirus disease. (1991) (12)
- California arbovirus (La Crosse) infections. III. Epidemiology of California encephalitis in Minnesota. (1976) (11)
- Effect of murine cytomegalovirus on cell-mediated immunity. (1977) (11)
- Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors. (2002) (11)
- Cytomegalovirus and acute cholecystitis. (1987) (10)
- Screening for Epstein–Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method (2019) (10)
- Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals (2001) (10)
- Increasing CD8+ T lymphocytes predict subsequent development of intraoral lesions among individuals in the early stages of infection by the human immunodeficiency virus. (1991) (9)
- ENCEPHALOMYOCARDITIS VIRUS‐INDUCED DIABETES MELLITUS TREATED BY ISLET TRANSPLANTATION (1979) (9)
- Comparison of reverse transcriptase assay with the Retro-Tek viral capture assay for detection of human immunodeficiency virus. (1987) (9)
- Antiviral Drug Development: The Road Less Taken (1996) (9)
- Clinical aspects of chickenpox and herpes zoster. (1994) (9)
- Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy. (2004) (9)
- Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team. (1999) (8)
- Cytomegalovirus and renal vein thrombosis in a newborn infant. (1974) (8)
- Serum is an acceptable specimen for measuring acyclovir levels. (1987) (8)
- Safety and Efficacy of zidovudine in asymptomatic HIV infected individuals withless than 500 CD4+ cells/mm3. (1990) (8)
- Transfusion and the human immunodeficiency virus (1993) (7)
- A method for evaluating antiviral drug susceptibility of Epstein-Barr virus (2010) (7)
- Evaluation of two commercial tests for human immunodeficiency virus antigens in culture supernatant fluid. (1988) (7)
- Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions. (1995) (7)
- Neutropenia in an HIV-1-infected renal transplant recipient treated with zidovudine. (1988) (7)
- Immediate loss of cell-mediated immunity to murine cytomegalovirus upon treatment with immunosuppressive agents. (1980) (7)
- Hoarseness as the presenting symptom of mitral insufficiency. (1968) (7)
- Meningoencephalitis and laboratory evidence of triple infection with California encephalitis virus, Echovirus II, and mumps. (1973) (6)
- Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. (2000) (6)
- HIV infection of the retina. (1988) (6)
- Transplantation of solid organ recipients shedding Epstein‐Barr virus DNA pre‐transplant: A prospective study (2017) (6)
- Prevention of cytomegalovirus disease with oral acyclovir (1991) (6)
- Liver Abscess due to Corynebacterium Acnes (1971) (6)
- Scalp abscesses following fetal blood sampling or monitoring. (1971) (5)
- Coinfection alters the playing field: herpesviruses induce acyclovir to inhibit HIV. (2008) (5)
- Fifth disease: full fathom five. (1976) (5)
- The clinical significance of infections with cytomegalovirus strains resistant to antiviral drugs. (1992) (5)
- Varicella-zoster-specific immune responses in acute herpes zoster during a placebo-controlled trial of oral acyclovir therapy. (1986) (5)
- Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions (1995) (5)
- Prevalence of oral lesions in symptomatic and asymptomatic HIV patients. (1994) (5)
- Prevention of cytomegalovirus disease. (1996) (5)
- Acyclovir for treatment of varicella in immunecompetent patients. (1991) (5)
- The surgical significance of viruses. (1977) (5)
- Therapeutic algorithm for treatment of cytomegalovirus retinitis in persons with AIDS. A roundtable summary. (1992) (4)
- Predictability and Complications of Fetal Blood Sampling (1968) (4)
- Viral and mycoplasmal pneumonias. (1975) (4)
- Primary virus isolation by a satellite laboratory. (1980) (4)
- Serological diagnosis of California (La Crosse) encephalitis by immunofluorescence (1975) (4)
- Acyclovir for immunocompromised patients with herpes zoster. (1983) (4)
- Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials. (1989) (4)
- Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. (2001) (4)
- Cytomegalovirus retinitis in persons with AIDS. (1995) (4)
- Cytomegalovirus infections and liver transplantation: an overview. (1993) (4)
- Human herpes virus 6 infections in hospitalized renal transplant recipients (1991) (4)
- Diagnosis of Viral Infections: The Role of the Clinical Laboratory (1980) (4)
- Hemophiliacs With HIV Seroconversion Associated With Heat-Treated Products: Are They Actively Infected?-Reply (1989) (3)
- Effect of blood exchange on acyclovir clearance in an infant with neonatal herpes. (1987) (3)
- Mumps Associated with Coma or Exanthems (1972) (3)
- Hemiatrophy and hemiparesis in a patient with congenital cytomegalovirus infection. (1975) (3)
- Diagnosis of California (La Crosse) encephalitis by precipitin techniques: a prospective study. (1974) (3)
- Epstein-Barr Virus and Cytomegalovirus (2016) (3)
- Prevalence of poliovirus neutralizing antibodies in young adult women. (1981) (3)
- The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease (2009) (3)
- Cytomegalovirus: The transplant troll takes its toll (1980) (3)
- California (La Crosse virus) encephalitis in Minnesota. (1974) (3)
- CALIFORNIA ARBOVIRUS (LA CROSSE) INFECTIONS (1973) (3)
- Herpes Diseases and Your Health (1984) (3)
- Cell-mediated immunity to cytomegalovirus in mice and in renal transplant recipients. (1979) (3)
- Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine (2020) (3)
- Cytomegalovirus infections in the immunocompromised transplant patient. Prevention of cytomegalovirus disease with oral acyclovir. (1991) (2)
- Editorial commentary: Genetics and infectious mononucleosis. (2014) (2)
- RIBAVIRIN THERAPY IN CRITICALLY ILL CHILDREN (1987) (2)
- Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. (1995) (2)
- Virus infections and kidney disease. (1975) (2)
- Detection of antiretroviral resistance in HIV-1. (2003) (2)
- Herpesvirus encephalitis following herpes keratitis. (1973) (2)
- Liver abscess in normal children with fever of unknown origin. (1978) (2)
- Complication of disseminated varicella-zoster infection. (1978) (2)
- Intermittent administration of high-dose stavudine to nucleoside-experienced individuals infected with HIV-1. (2003) (2)
- Epstein-Barr virus infection status among first year undergraduate university students (2020) (2)
- Lithium for Zidovudine-Induced Neutropenia in AIDS-Reply (1988) (2)
- Herpes Group Viruses and HIV Infection (2004) (1)
- [Treatment of varicella]. (1997) (1)
- Rubella Vaccination-Reply (1979) (1)
- Herpes Simplex Virus Resistant to Acyclovir (2020) (1)
- [Varicella: how and when to start antiviral treatment]. (1993) (1)
- Clinical, Viral and Antibody Kinetics during Infectious Mononucleosis (IM) (2007) (1)
- Advances in clinical virology. (1981) (1)
- Genetics and Infectious Mononucleosis (2014) (1)
- Prevention of Viral Infections During Pregnancy (1982) (1)
- Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection. (2022) (1)
- Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40 (1992) (1)
- Virologic and CD 4 Cell Response to Zidovudine or Zidovudine and Lamivudine Following Didanosine Treatment of Human Immunodeficiency Virus Infection (2004) (1)
- Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures (1989) (1)
- Recurrent ocular herpes simplex infection. (1994) (1)
- Acyclovir for childhood chickenpox: Author’s reply. (1995) (1)
- Antibody response following customary use of MMR vaccine. (1984) (1)
- ADA activity in spleen cells from mice infected with cytomegalovirus. (1979) (1)
- Letter: Rapid diagnosis of arbovirus infections by counterelectrophoresis. (1974) (1)
- Immunosuppressive plasma factors in transplant recipients with viral infections. (1974) (1)
- Immunosuppression-Induced Defective Lymphocyte Proliferation to Murine Cytomegalovirus Is Prolonged following the Cessation of Immunosuppression 1 (1983) (1)
- Use of acyclovir for varicella (Reply) (1991) (1)
- Use of semiquantitative human immunodeficiency virus type 1 culture to guide therapy in a premature infant. (1994) (0)
- Immortalization and functional screening of natively paired human T cell receptor repertoires. (2022) (0)
- Mutations in cytomegalovirus ul97 and dna polymerase: structural models of the effects on drug resistance (1997) (0)
- Serological Diagnosis ofCalifornia (LaCrosse) Encephalitis by Immunofluorescence (1975) (0)
- A PROSPECTIVE RANDOMIZED STUDY OF ACYCLOVIR VERSUS GANCICLOVIR PLUS HUMAN IMMUNE GLOBULIN PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION AFTER SOLID ORGAN TRANSPLANTATION1,2 (1994) (0)
- disease in renal allograft recipients. acyclovir prophylaxis of cytomegalovirus Pharmacologic basis for high-dose oral (2013) (0)
- Immortalization and Functional Screening of Natively Paired Human T Cell Receptor Repertoires (2021) (0)
- Zoster immune plasma for prevention or treatment of varicella zoster infections in immunocompromised patients (1976) (0)
- AIDS. Treatment strategies and the Minnesota AIDS Clinical Trials Unit. (1988) (0)
- How today's serologic techniques can detect viral antibodies. (1977) (0)
- Adjuvant effect of recurrent murine cytomegalovirus (MCMV) infection (1977) (0)
- ACYCLOVIR THERAPY IN NEONATES. AUTHOR'S REPLY (1992) (0)
- Response of immunocompromised patients with acute herpes zoster to intravenous acyclovir. (1987) (0)
- Childhood respiratory infections with evidence of viral-streptococcal interaction. (1982) (0)
- Plasmacytoid DC declined in the circulation during the incubation period and remained depressed through convalescence. (2015) (0)
- Age-Speci fi c Prevalence of Epstein-Barr Virus Infection Among Minnesota Children: Effects of Race/Ethnicity and Family Environment (2014) (0)
- Predictive Value of HIV‐1 Viral Load on Risk for Opportunistic Infection (2002) (0)
- Epstein-Barr Virus (2021) (0)
- Forceps delivery and auriculotemporal syndrome (1971) (0)
- Pharmacologic Basis forHigh-Dose OralAcyclovir Prophylaxis of Cytomegalovirus Disease inRenalAllograft Recipients (1991) (0)
- Thanks to Reviewers2000 (2000) (0)
- Varicella immunity in adults. (1980) (0)
- USE OF ACYCLOVIR FOR VARICELLA. AUTHORS' REPLY (1991) (0)
- Prevention and treatment of cytomegalovirus (CMV) disease (1997) (0)
- Clinical aspects of chickenpox and herpes zoster. Discussion (1994) (0)
- 22 – Epstein-Barr Virus Vaccines (2018) (0)
- Why bother with the clinical virology laboratory (1979) (0)
- Reversal of encephalomyocarditis virus-induced diabetes mellitus by islet transplantation. (1979) (0)
- American Transplant Congress 2009 Program Planning Committees (2009) (0)
- Sensitive Microculture MethodforIsolation ofHuman Immunodeficiency Virus Type1fromBloodLeukocytes (1992) (0)
- Fifth disease and arthritis: common immune-mediated responses to parvovirus infection. (1986) (0)
- Letter: Measles immunity and revaccination. (1976) (0)
- The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection (2020) (0)
- Continuous Infusion ofHigh-Dose Acyclovir forSerious Herpesvirus Infections (1989) (0)
- Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine (2022) (0)
- Acyclovir therapy in 129 immunocompromised patients with herpesvirus infections (1982) (0)
- 28 Analysis of the Cytomegalovirus (CMV) gB vaccine with MF 59 adjuvant (CMVgB) in CMV seronegative patients with renal failure on a transplant list (2006) (0)
- Gene expression signatures during the incubation period showed distinct kinetic patterns. (2015) (0)
- A Real-time TaqMan PCR Assay for Quantitation of Cytomegalovirus (CMV) in Whole Blood (WB), Plasma and Peripheral Blood Leukocytes (PBL) and Comparison with the pp65 Antigenemia Test (2006) (0)
- Measles Immunity and Revaccination (1976) (0)
- Effect of antivirals on risk of genital herpes transmission (1998) (0)
- Mice lose cell-mediated immunity to murine cytomegalovirus (MCMV) 3 hours after immunosuppression with antilymphoblast globulin and prednisolone (1980) (0)
- Viral genome detection during the incubation period. (2015) (0)
- A VIROLOGICAL STUDY OF HUMAN KIDNEY EXPLANT CULTURES FROM RENAL ALLOGRAFT RECIPIENTS (1978) (0)
- Diagnosis of California (La Crosse) Encephalitis by Precipitin Techniques: a Prospective Study (1974) (0)
- Acyclovir reduces but does not eliminate - The risk of herpes transmission (1997) (0)
- COMPLICATIONS OF FETAL SCALP BLOOD SAMPLING (1971) (0)
- Practical virology: indications and yield. (1975) (0)
- Varicella-zoster infections. Advances in the prevention and treatment. (1983) (0)
- DAPSONE FOR PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH HIV INFECTION ATOVAQUONE COMPARED WITH DAPSONE FOR THE PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH HIV INFECTION WHO CANNOT TOLERATE TRIMETHOPRIM , SULFONAMIDES (2017) (0)
- Transmission of zidovudine-resistant AIDS virus report (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Henry H. Balfour?
Henry H. Balfour is affiliated with the following schools:
